entertainment -WSS

entertainment

author：comprehensive 2025-10-02 20:48:24 - browse：45849

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Let's speed up science by embracing open access publishing

WSS

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Bird flu outbreak in cows is latest avian flu curveball

FDA's Pazdur wants cancer trials to range beyond China alone

Woman returns to dialysis after doctors remove transplanted pig kidney

Cue Health's Covid

Close Medicare's dangerous gaps in addiction treatment coverage

hotspot

entertainment

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Q&A: Jennifer Adair on making gene therapy available globally

Medicare proposal to cover medical devices draws a mixed reaction

Bird flu in milk supply is likely coming from asymptomatic cows

Peter Hotez and the public health issue of online harassment

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth financials solid despite Change Healthcare cyberattack

23andMe had bad news about my health. I wish a person had delivered it

Kaiser's Risant Health gobbled up Geisinger. Who is next?

focus

Orangutan used medicinal plant to treat wound, first time ever seen

Q&A: Jennifer Adair on making gene therapy available globally

More tobacco lobbyists active in statehouses

FTC falls short on scrutinizing hospital mergers, study says

MultiPlan and major insurers sued for alleged medical price

BMI, flaws aside, is found to be useful estimate of body fat in youth

knowledge

focus

Wikipedia

knowledge